skip to content

Cambridge Academy of Therapeutic Sciences

Read more at: WT Developing Concept Fund

WT Developing Concept Fund

WT Developing Concept Fund The Wellcome Trust has awarded Cambridge University an Institutional Translational Partnership Award (iTPA). The Developing Concept Fund is intended to pump-prime the translation of novel therapeutics, devices and diagnostics, including repurposing of existing therapies towards a clinical end. It...

Read more

Read more at: Industry Experts in Residence (EiRs)

Industry Experts in Residence (EiRs)

The Industry Experts in Residence are available to University of Cambridge staff for: Advice on the applicability of specific ideas to drug discovery, diagnostics & devices Advice on translational grant applications Discussions about progression of current translational research projects Work in conjunction with...

Read more

Read more at: MPhil in Therapeutic Sciences

MPhil in Therapeutic Sciences

The University of Cambridge and The Cambridge Academy of Therapeutic Sciences launched the new and innovative MPhil in Therapeutic Sciences in Autumn 2018. We are currently recruiting for the second cohort of students, due to begin in October 2020. This one-year full-time course will select a cohort of students with the...

Read more

Read more at: WT Access to Expertise

WT Access to Expertise

THIS CALL IS CURRENTLY CLOSED, WE WILL INFORM YOU ABOUT OPENING OF NEW ROUND ON THIS PAGE IN THE FUTURE. Cambridge Academy of Therapeutic Sciences (CATS) is offering an access to external consultancy services for translational research projects through its Access to Expertise (AtE). AtE is an internal call supported by...

Read more

Latest news

€2m boost for gene and cell therapy info hub

15 April 2021

A new EU-funded project is set to provide accessible and reliable information about cell and gene-based therapies. The € 2m initiative will develop an online hub to provide accurate information on the use of cells and genetic material to treat disease, along with evidence-based information to counter misinformation...

Researchers call for greater awareness of unintended consequences of CRISPR gene editing

15 April 2021

CRISPR-Cas9 genome editing can lead to unintended mutations at the targeted section of DNA in early human embryos, researchers have revealed. This highlights the need for further research into the effects of CRISPR-Cas9 genome editing, especially when used to edit human DNA in laboratory research. We and others are trying...

Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital

26 March 2021

A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19. Having survived the trauma of being hospitalised with COVID-19, far too many patients find themselves back in hospital with new or long term complications Charlotte Summers The clinical trial...